Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Email this article to a Colleague Similar articles in this journal Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via Google Scholar Articles by Mischoulon, D. Articles by Messner, E. Search for Related Content Articles by Mischoulon, D. Articles by Messner, E. Other Treatment

Transfer to a New Psychopharmacologist

Its Effect on Patients

Dr. Mischoulon is at the Department of Psychiatry, Massachusetts General Hospital, WAC-812, 15 Parkman Street, Boston, MA 02114. Address reprint requests to Dr. Mischoulon. e-mail: dmischoulon{at}partners.org

The authors surveyed 38 psychiatry residents to determine the effect of end-of-residency transfer of care on psychopharmacology patients. Senior residents reported that 19% of patients worsened after notification about the upcoming transfer, 32% required medication changes, and up to 9% became noncompliant. Junior residents reported that, after transfer, 10% of patients worsened, 7% required medication changes, and up to 12% became noncompliant. Approximately 29% of patients considered the change of residents a major treatment disruption. The authors propose a system for minimizing deleterious effects and improving outcome in the transfer of psychopharmacology patients.

Key Words: Delivery of Care • Psychopharmacology

Get information about faster international access.

Privacy Policy

Copyright © 2000 Academic Psychiatry. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us